Patent · US Active

Predicting response to therapy for adult and pediatric crohn's disease using radiomic features of mesenteric fat regions on baseline magnetic resonance enterography

US11241190B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2019
Grant dateFeb 8, 2022
Priority date
Expiry dateApr 15, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG06V2201/031
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Embodiments discussed herein facilitate predicting response to therapy in Crohn's disease. A first set of embodiments discussed herein relates to accessing a radiological image of a region of tissue demonstrating Crohn's disease associated with a patient; defining a mesenteric fat region by segmenting mesenteric fat represented in the radiological image; extracting a set of radiomic features from the mesenteric fat region; providing the set of radiomic features to a machine learning classifier configured to compute a probability of response to therapy in Crohn's disease based, at least in part, on the set of radiomic features; receiving, from the machine learning classifier, a probability that the region of tissue will respond to therapy; generating a classification of the patient as a responder or non-responder based, at least in part, on the probability; and displaying the classification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.